Poor Children as Big Pharma’s Lab Rats
By K. S. Harikrishnan, IPS | Staff, Rediff Business. American pharmaceutical companies, taking advantage of a Congressional provision called The Pediatric Exclusivity Provision, have been carrying out clinical trials in poor and developing countries where the drugs might never be available.
Continue reading →